Fingerprint
Dive into the research topics of 'Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
Clive S. Zent, Timothy G. Call, Tait D. Shanafelt, Renee C. Tschumper, Diane F. Jelinek, Deborah A. Bowen, Charla R. Secreto, Betsy R. LaPlant, Brian F. Kabat, Neil E. Kay
Research output: Contribution to journal › Article › peer-review
71
Scopus
citations